Versant Capital Management’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.49K | Buy |
69
+32
| +86% | +$4.4K | ﹤0.01% | 1912 |
|
|
2025
Q1 | $6.67K | Sell |
37
-16
| -30% | -$2.89K | ﹤0.01% | 1914 |
|
|
2024
Q4 | $8.3K | Sell |
53
-22
| -29% | -$3.45K | ﹤0.01% | 1511 |
|
|
2024
Q3 | $13.7K | Buy |
75
+29
| +63% | +$5.28K | ﹤0.01% | 950 |
|
|
2024
Q2 | $8.45K | Buy |
46
+38
| +475% | +$6.98K | ﹤0.01% | 1043 |
|
|
2024
Q1 | $1.42K | Hold |
8
| – | – | ﹤0.01% | 1453 |
|
|
2023
Q4 | $992 | Hold |
8
| – | – | ﹤0.01% | 1513 |
|
|
2023
Q3 | $928 | Hold |
8
| – | – | ﹤0.01% | 1548 |
|
|
2023
Q2 | $939 | Buy |
+8
| New | +$939 | ﹤0.01% | 1622 |
|